Patents by Inventor Meehae Kim

Meehae Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11795438
    Abstract: Provided are a method for promoting the proliferation of pluripotent stem cells and a proliferation promoting composition used in the method. In one aspect, a composition for promoting the proliferation of pluripotent stem cells includes hemagglutinin or modified hemagglutinin. In another aspect, a method for promoting the proliferation of pluripotent stem cells includes culturing pluripotent stem cells in a culture medium to which the proliferation promoting composition of the present disclosure has been added.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: October 24, 2023
    Assignee: Osaka University
    Inventors: Masahiro Kinooka, Meehae Kim, Yukako Fujinaga
  • Publication number: 20220290106
    Abstract: Provided is a method that is able to simply promote cell proliferation. An aspect relates to a method for promoting proliferation of cells. The method includes adding a precursor of AGES to a culture medium containing a cell aggregate, and culturing the cell aggregate in the culture medium to which the precursor of AGEs has been added.
    Type: Application
    Filed: July 10, 2020
    Publication date: September 15, 2022
    Applicant: Osaka University
    Inventors: Masahiro Kinooka, Meehae Kim
  • Patent number: 11230701
    Abstract: Provided are a novel hemagglutinin that can remove cells deviated from the undifferentiated state, the cells being cells that emerge in a colony during culture of stem cells having pluripotency, and a novel method for culturing stem cells having pluripotency, the method using hemagglutinin. Provided is a mutant hemagglutinin complex protein derived from Clostridium botulinum type B, the complex protein containing at least subcomponents HA2 and HA3 of hemagglutinin derived from Clostridium botulinum type B, and the complex protein containing amino acids constituting a glycosylation site, with at least one of the amino acids having been mutated. Provided is a method for culturing stem cells having pluripotency, the method including culturing the stem cell having pluriopotency in the presence of a mutant hemagglutinin complex protein of the present disclosure.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: January 25, 2022
    Assignee: Osaka University
    Inventors: Masahiro Kinooka, Meehae Kim, Yukako Fujinaga, Yo Sugawara
  • Publication number: 20200017836
    Abstract: Provided are a method for promoting the proliferation of pluripotent stem cells and a proliferation promoting composition used in the method. In one aspect, a composition for promoting the proliferation of pluripotent stem cells includes hemagglutinin or modified hemagglutinin. In another aspect, a method for promoting the proliferation of pluripotent stem cells includes culturing pluripotent stem cells in a culture medium to which the proliferation promoting composition of the present disclosure has been added.
    Type: Application
    Filed: December 19, 2017
    Publication date: January 16, 2020
    Applicant: Osaka University
    Inventors: Masahiro Kinooka, Meehae Kim, Yukako Fujinaga
  • Patent number: 9822344
    Abstract: Provided is a method by which cells deviated from the undifferentiated state, which emerge in a colony during culture of stem cells having pluripotency, can be removed. In one aspect, provided is a method for culturing stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In another aspect, provided is a method for removing cells deviated from the undifferentiated state, the cells being cells that have emerged or may possibly emerge during culture of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In still another aspect, provided is a method for maintaining the undifferentiated state of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion.
    Type: Grant
    Filed: December 26, 2013
    Date of Patent: November 21, 2017
    Assignee: Osaka University
    Inventors: Masahiro Kinooka, Meehae Kim, Yukako Fujinaga, Yo Sugawara
  • Publication number: 20170130206
    Abstract: Provided are a novel hemagglutinin that can remove cells deviated from the undifferentiated state, the cells being cells that emerge in a colony during culture of stem cells having pluripotency, and a novel method for culturing stem cells having pluripotency, the method using hemagglutinin. Provided is a mutant hemagglutinin complex protein derived from Clostridium botulinum type B, the complex protein containing at least subcomponents HA2 and HA3 of hemagglutinin derived from Clostridium botulinum type B, and the complex protein containing amino acids constituting a glycosylation site, with at least one of the amino acids having been mutated. Provided is a method for culturing stem cells having pluripotency, the method including culturing the stem cell having pluriopotency in the presence of a mutant hemagglutinin complex protein of the present disclosure.
    Type: Application
    Filed: June 29, 2015
    Publication date: May 11, 2017
    Applicant: Osaka University
    Inventors: Masahiro Kinooka, Meehae Kim, Yukako Fujinaga, Yo Sugawara
  • Publication number: 20150329831
    Abstract: Provided is a method by which cells deviated from the undifferentiated state, which emerge in a colony during culture of stem cells having pluripotency, can be removed. In one aspect, provided is a method for culturing stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In another aspect, provided is a method for removing cells deviated from the undifferentiated state, the cells being cells that have emerged or may possibly emerge during culture of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In still another aspect, provided is a method for maintaining the undifferentiated state of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion.
    Type: Application
    Filed: December 26, 2013
    Publication date: November 19, 2015
    Applicant: OSAKA UNIVERSITY
    Inventors: Masahiro Kinooka, Meehae Kim, Yukako Fujinaga, Yo Sugawara